ATI RN
Pediatric ATI Practice Questions Questions
Question 1 of 5
A 5-year-old boy is one of the shortest in class. His father is 6' tall and his mother 5'7'. What should the nurse tell his mother?
Correct Answer: B
Rationale: The correct answer is B) He is expected to grow about 2 inches per year from ages 6 to 9. This response aligns with typical growth patterns for children in this age group. It is important for the nurse to convey this information to the mother to provide reassurance and set appropriate growth expectations for the child. Option A) He is expected to grow about 3 inches per year from ages 6 to 9 is incorrect because a growth rate of 3 inches per year would be considered higher than the average for this age group. Option C) He should be evaluated by an endocrinologist for growth hormone injections is incorrect because at this point, there is no indication that the child's growth is abnormal or warrants medical intervention. Option D) His growth will be re-evaluated when he is 7 years old is incorrect because waiting until the child is 7 years old to re-evaluate may delay any necessary interventions if there were concerns about his growth trajectory. In an educational context, understanding typical growth patterns in children is essential for healthcare providers working with pediatric populations. By knowing what is considered normal growth, nurses can provide appropriate guidance to parents and caregivers and identify any deviations from the norm that may require further evaluation.
Question 2 of 5
Oral medications are often used as an early treatment for generalized spasticity. Which of the following works at the level of skeletal muscle to block calcium release from the sarcoplasmic reticulum?
Correct Answer: A
Rationale: In the context of pediatric practice, understanding the mechanisms of action of medications used for spasticity management is crucial. The correct answer is A) dantrolene sodium. Dantrolene works at the level of skeletal muscle by directly blocking calcium release from the sarcoplasmic reticulum. This action helps to reduce muscle contraction and spasticity, making it an effective early treatment for generalized spasticity. Now, let's discuss why the other options are incorrect: - B) Clonidine primarily acts as a centrally acting alpha-2 adrenergic agonist, targeting the central nervous system to reduce sympathetic outflow. It is not directly involved in blocking calcium release from the sarcoplasmic reticulum in skeletal muscle. - C) Tizanidine is another centrally acting alpha-2 adrenergic agonist that works by reducing spasticity through its effect on the central nervous system, rather than at the level of skeletal muscle. - D) Baclofen is a GABA receptor agonist that acts at the spinal cord level to reduce muscle spasticity. It does not directly block calcium release from the sarcoplasmic reticulum in skeletal muscle. Educationally, understanding the specific mechanisms of action of medications used in pediatric spasticity management not only helps in answering exam questions correctly but also enhances clinical decision-making skills when caring for pediatric patients with spasticity disorders. This knowledge is essential for safe and effective medication administration and optimal patient outcomes.
Question 3 of 5
A 3-year-old child has recurrent attacks of screaming, vomiting, and biting other children, these attacks lasts 2-5 minutes and occurs once or twice weekly, the child looks well between the attacks.
Correct Answer: D
Rationale: In this scenario, the correct answer is D) temper tantrums. Temper tantrums are common in young children, particularly in the toddler and preschool years, as they are still developing emotional regulation skills. The description of the child having recurrent episodes of screaming, vomiting, and biting other children that last for a short duration (2-5 minutes) and occur once or twice weekly, but appearing well between episodes, is characteristic of temper tantrums. Autism (option A) is a neurodevelopmental disorder characterized by challenges in social skills, communication, and repetitive behaviors. The child in the question does not exhibit the hallmark signs of autism such as social communication deficits or restricted/repetitive behaviors. Traumatic brain injury (option B) typically presents with a history of head trauma and can lead to a variety of symptoms depending on the severity and location of the injury. The symptoms described in the question are not consistent with those typically seen in traumatic brain injury. Cognitive impairment (option C) refers to limitations in cognitive functioning and adaptive behaviors. While cognitive impairment can manifest in various ways, the symptoms described in the question are more indicative of emotional dysregulation rather than cognitive deficits. Educationally, understanding the developmental stage of children and common behaviors exhibited during different stages is crucial for healthcare providers working with pediatric populations. Recognizing the difference between normal developmental milestones like temper tantrums and symptoms of more serious conditions helps in accurate assessment and intervention planning for children's well-being.
Question 4 of 5
Which of the following chromosomal abnormalities of childhood ALL carries the highest risk of relapse despite intensive chemotherapy?
Correct Answer: A
Rationale: In pediatric oncology, understanding the different chromosomal abnormalities associated with childhood acute lymphoblastic leukemia (ALL) is crucial for determining appropriate treatment strategies and predicting outcomes. The correct answer is A) t(9;22), also known as the Philadelphia chromosome. This abnormality results in the BCR-ABL1 fusion gene, which is associated with a high risk of relapse in childhood ALL despite intensive chemotherapy. This is because the presence of the Philadelphia chromosome confers resistance to standard treatments, leading to poor outcomes. Option B) t(4;11) is associated with the MLL gene rearrangement and is generally considered a high-risk feature in childhood ALL due to its association with a poor prognosis. However, it does not carry the highest risk of relapse compared to t(9;22). Option C) hypodiploidy, which refers to having fewer than the normal number of chromosomes, is also a high-risk feature in childhood ALL. It is associated with a poorer response to treatment but does not carry as high a risk of relapse as t(9;22). Option D) t(1;19) is associated with the E2A-PBX1 fusion gene and is considered an intermediate-risk feature in childhood ALL. While it may impact treatment response, it does not carry the same level of relapse risk as t(9;22). Educationally, understanding the significance of different chromosomal abnormalities in childhood ALL is essential for healthcare providers involved in the care of pediatric oncology patients. Recognizing the implications of these genetic alterations helps guide treatment decisions and prognostication, ultimately improving patient outcomes.
Question 5 of 5
Which of the following is MOST likely considered a risk factor for extraneural metastasis in primary brain tumors?
Correct Answer: A
Rationale: The correct answer is A) age less than 10 years. This is considered a risk factor for extraneural metastasis in primary brain tumors because pediatric patients with brain tumors are more likely to develop metastases outside of the central nervous system due to their immature immune system and higher likelihood of hematogenous spread. Option B) female gender is not a significant risk factor for extraneural metastasis in primary brain tumors. Gender does not play a direct role in the spread of tumors outside of the brain. Option C) ventriculoperitoneal (VP) shunt insertion is a treatment modality for managing increased intracranial pressure in patients with brain tumors. While it may have its own set of complications, it is not directly linked to extraneural metastasis. Option D) supratentorial tumor location is not a direct risk factor for extraneural metastasis. Tumor location may impact symptoms and treatment options but does not determine the likelihood of metastases outside of the central nervous system. Understanding risk factors for extraneural metastasis in pediatric brain tumors is crucial for healthcare providers involved in the care of these patients. Recognizing age as a significant risk factor can guide treatment decisions and surveillance strategies to improve patient outcomes. It highlights the importance of considering the unique characteristics of pediatric patients when managing primary brain tumors.